An observational study in Premature Ejaculation, sponsored by OZGUR EKICI. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-25.
Sponsored by OZGUR EKICI · Observational
Among 14 studies in Premature Ejaculation with a site in Turkey — 3 open to participants now, 3 under way, none of them phase 3. Premature Ejaculation · Turkey.
Among the 14 studies in Premature Ejaculation with a site in Turkey, this one is the only one that started in 2024, is one of 4 observational ones, and was the 7th registered.
106 studies on the registry are indexed under Premature Ejaculation; 17 are open to participants now.
This study's enrollment of 54 is below the median of 600 across 17 observational studies indexed under Premature Ejaculation.
Browse Premature Ejaculation studies →3 of the 14 studies in Premature Ejaculation with a site in Turkey are open now, in 1 country. Each count lists the studies.
Of the 9 Premature Ejaculation studies recruiting now, 2 (22%) set no upper age limit and 6 (67%) stop at 75 or younger; 0 take children under 18; 3 take healthy volunteers.
This study: 18 Years to 60 Years · male · healthy volunteers too.
The full table on the hub →14 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 1 started in 2024.
Median enrollment 67 across the 10 interventional studies, 102 across the 4 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
2 of 14 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with OZGUR EKICI as lead sponsor.
OZGUR EKICI has 1 study filed under Premature Ejaculation — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 14 studies in Premature Ejaculation with a site in Turkey, from their registry updates:
Aim: To investigate whether intramuscular B12 treatment has an effect on ejaculation in male patients with B12 deficiency.
Methods: Male patients who were diagnosed with vitamin B12 deficiency in the internal medicine outpatient clinic between October 2024 and March 2025 and started intramuscular B12 treatment were included in the study. The scores obtained from the self-estimated intravaginal ejaculation latency time (IELT), premature ejaculation diagnostic tool (PEDT) and premature ejaculation profile (PEP) questionnaires reflecting the ejaculatory status of these patients before treatment were recorded. After 3 months of treatment, these scores were re-recorded by phone call.
The scores recorded before and after treatment were compared. Results: The study included 54 patients. The mean age of the patients was 43.46±13.3 years, mean pretreatment IELT was 2.4±1.4 min, and mean pre-treatment PEDT score was 11.3±4.8. In both the whole patient group and the premature ejaculation (PE) group, a statistically significant difference was observed in the items of perceived control over ejaculation, satisfaction with sexual intercourse and interpersonal difficulty related to ejaculation from the PEP questionnaire form after treatment, no significant change was found in the item of personal distress related to ejaculation.
PEDT scores showed statistically significant improvement after treatment both in the whole patient group and in the PE group. In terms of IELT, no differences was observed in the whole patient group after treatment, whereas statistically significant improvement was observed in the PE group.
Conclusion: Intramuscular vitamin B12 may improve ejaculation times and satisfaction levels in patient's questionnaires forms in male patients.
Male patients aged 18-70 years who were admitted to the internal medicine outpatient clinic of Bursa City Hospital between October 2024 and March 2025 with non-specific gastrointestinal complaints or to investigate the etiology of anemia and who were started on intramuscular vitamin B12 due to vitamin B12 deficiency were included in the study
Male patients aged 18-70 years who were admitted to the internal medicine outpatient clinic between October 2024 and March 2025 with non-specific gastrointestinal complaints or to investigate the etiology of anemia and who were started on intramuscular vitamin B12 due to vitamin B12 deficiency were included in the study
-
Vitamin B12 treatment was initiated in male patients with vitamin B12 deficiency due to anemia etiology.
intravaginal ejaculation latency time after treatment
intravaginal ejaculation latency time after treatment
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2024 to primary completion in Mar 2025, 5 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.